Mon.Aug 14, 2023

article thumbnail

Illinois Governor Signs Legislation Targeting PBM Retaliation

Drug Topics

Illinois Governor JB Pritzker signed into a law a bill prohibiting PBM retaliation against pharmacists who disclose information during government proceedings.

469
469
article thumbnail

Pharma’s rare disease rush

PharmaVoice

Biogen’s acquisition of Reata Pharmaceuticals is the latest in a string of high-dollar rare disease deals over the last few months. What does it mean for industry?

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Expert Interview: Exploring the Full Capabilities of Generative AI

Drug Topics

Generative AI is the fastest growing technology ever, and is anticipated to be adopted faster than the world wide web.

460
460
article thumbnail

Study Finds Sugar-Sweetened, Artificially Sweetened Beverages Associated With Risk of Liver Cancer, Chronic Liver Disease Mortality

Pharmacy Times

Study authors note that additional research is necessary to confirm findings and identify biological pathways of associations between sweetened beverages and diseases of the liver.

123
123
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

US Representatives From Ohio, New Hampshire Write Bipartisan Letter to FDA Warning of Potential DSCSA Problems

Drug Topics

The act is currently set to go into effect in just over three months.

FDA 247
article thumbnail

Look-Alike Packaging, Drug Shortages Continue to Contribute to Medication Errors

Pharmacy Times

Because the generic name of both the timolol once-daily and twice-daily formulations is the same, pharmacies should only carry 1 formulation.

Packaging 123

More Trending

article thumbnail

Expert Panel Discusses Community Solutions to Advance Food is Medicine Programs

Pharmacy Times

Session at NACDS Total Store Expo discusses how pharmacies can leverage their accessibility to decrease diet-related diseases through health and wellness.

123
123
article thumbnail

Long-term exposure to particulates from wildfire smoke linked to dementia risk, new study finds

STAT

Smoke permeates everything and impacts everyone. The visible stew of carbon and particulates typically from emission sources travels in the air, shrouds buildings, suffocates birds, and penetrates deep into the lungs. Now researchers believe wildfire smoke may impact the brain too. Scientists found that people living in areas with high levels of fine particulate matter, or PM2.5, could have a greater risk of developing dementia in their late stage of life.

98
article thumbnail

FDA Approves New Combination Therapy for BRCA-Positive Metastatic Castration-Resistant Prostate Cancer

Pharmacy Times

Niraparib and abiraterone acetate (Akeega; Janssen Pharmaceutical Companies of Johnson & Johnson) is the first-and-only dual action tablet that combines a PARP inhibitor with abiraterone acetate administered with prednisone.

article thumbnail

Opinion: I’m a dentist. I’m begging people not to give up on aspartame

STAT

The International Agency for Research on Cancer (IARC, an entity within the World Health Organization) recently announced that aspartame, a sugar substitute used in about 6,000 products worldwide, is “possibly carcinogenic to humans.” If this sounds familiar, it’s because reports of this assessment have circulated for two weeks, after anonymous sources leaked it to the press.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Weight Loss, Alzheimer Drugs Are Top of Mind for the 2023/24 Market

Pharmacy Times

Expert weighs in on the growth of specialty drug spending, particularly with drugs in immunology, neurology, and weight loss.

123
123
article thumbnail

Listen: How Long Island became the ‘eugenics capital of the world’

STAT

The study of eugenics wasn’t born on Long Island — it’s closer to say it went through puberty there. The idea of eugenics — a pseudoscience that promoted the idea that certain people or groups should be removed from the human gene pool — originated in England with Francis Galton, a cousin of Charles Darwin. Galton took the emerging ideas of evolution and genetics and attempted to apply them to human society.

98
article thumbnail

FDA Grants Accelerated Approval to Elranatamab-bcmm for Relapsed or Refractory Multiple Myeloma

Pharmacy Times

Elranatamab-bcmm (Elrexfio; Pfizer) is a BCMA-CD3-targeted bispecific antibody approved for adults with relapsed or refractory multiple myeloma who were previously administered at least 4 lines of therapy that included a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.

FDA 123
article thumbnail

STAT+: Hospitals are dialing back on venture capital investing

STAT

Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back. NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office ȁ

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Study Finds Myasthenia Gravis Not Caused by Vitamin D Deficiency, Counter to Prior Research

Pharmacy Times

Previous studies were not able to establish whether the risk of developing myasthenia gravis was caused by or led to vitamin D deficiency.

122
122
article thumbnail

STAT+: What’s behind the recent surge in Apellis’ stock price? Growing confidence in the safety of its eye treatment

STAT

Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that the serious safety issue that has derailed Syfovre, the company’s eye disease treatment, is receding. Declaring the crisis over is premature, but that could change with more uneventful weeks. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value.

98
article thumbnail

Amazon Pharmacy's latest move aims to ease access to affordable insulin

Fierce Healthcare

Amazon has been focused on ways to make prescription drugs more affordable for consumers as it works to carve out a piece of the retail pharmacy market. | Amazon Pharmacy will automatically apply drug manufacturer-sponsored coupons on more than 15 insulin and diabetes care brands during online check-out. With the coupons, many insulin brands are available to eligible customers starting at $35 a month with free delivery.

98
article thumbnail

STAT+: Not-for-profit CommonSpirit Health paid its CEO $35 million in 2021

STAT

CommonSpirit Health, the massive not-for-profit health system formed through a 2019 merger, paid its former CEO $35.5 million in 2021, the latest year for which data is available.  The size of Lloyd Dean’s pay package is likely to reignite questions about health system CEO pay, especially at tax-exempt organizations. It’s more than twice the total compensation paid to the CEO of Ascension, a comparably sized not-for-profit system, and puts him in the upper tier of many for-pro

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

World Lung Cancer Day: Why awareness days matter

pharmaphorum

World Lung Cancer Day: Why awareness days matter Mike.

98
article thumbnail

STAT+: After Optum Health’s lowest profit margin in a decade, UnitedHealth makes changes

STAT

Just weeks after the division of UnitedHealth Group that provides care to patients posted its lowest profit margin in a decade, the company has shuffled around several top executives. Amar Desai is now CEO of Optum Health, according to a July LinkedIn post. Optum Health encompasses UnitedHealth’s physician practices, surgery centers, urgent care clinics, and other providers.

article thumbnail

Smoked out: Smoking cessation products on the rise

Drug Store News

A dive into smoking cessation methods and means of harm reduction.

98
article thumbnail

Chutes & Ladders—Cleveland Clinic hires first chief analytics officer; Express Scripts exec to work with independent pharmacies

Fierce Healthcare

Chutes & Ladders—Cleveland Clinic hires first chief analytics officer; Express Scripts exec to work with independent pharmacies ntong Mon, 08/14/2023 - 10:37

article thumbnail

STAT+: In the case of a devastating disease, the FDA weighs an experimental drug’s muddled data and a desperate need

STAT

Emma Albee knows the experimental drug she takes is not a cure. It won’t allow her to stop using the wheelchair she’s relied on since adolescence, and it’s not going to take away the latticework of bone that has locked her hips in place. But for Albee and the roughly 1,000 people with a rare genetic disorder that causes their body to grow rigid bone where it doesn’t belong, the drug symbolizes a future in which years of research, advocacy, and tireless fundraising mig

FDA 98
article thumbnail

Structured Agendas for Productive Hospital Leadership Meetings with Free Sample

indispensable health

Introduction In the fast-paced and intricate world of healthcare, seamless coordination between various departments is crucial to ensure quality patient care and effective administration. One pivotal collaboration exists between the hospital president or administrator and the director of the pharmacy. To maximize the efficiency and effectiveness of their routine interactions, a well-structured agenda is essential.

article thumbnail

CVS Health Foundation awards $6.6M in grants to improve maternal health outcomes

Drug Store News

CVS Health is awarding $6.6 million in grants to Massachusetts General Hospital, the American Heart Association and March of Dimes to remove barriers to maternal health services.

article thumbnail

Botulinum battle heats up with FDA approving Daxxify for cervical dystonia

Pharmaceutical Technology

Daxxify becomes the latest botulinum toxin to make the jump from aesthetics to therapeutics.

FDA 98
article thumbnail

Southeastern Grocers launches community donation program benefiting more than 420 local schools

Drug Store News

SEG's third annual donation program will support learning environments for the upcoming school year.

98
article thumbnail

Pfizer joins off-the-shelf BCMA fight with Elrexfio okay

pharmaphorum

Pfizer joins off-the-shelf BCMA fight with Elrexfio okay Phil.

98
article thumbnail

Lilly completes biopharma acquisitions

European Pharmaceutical Review

Eli Lilly and Company has completed acquisition of two biopharmaceutical companies – Versanis Bio and Sigilon Therapeutics – and their lead assets focused on obesity and diabetes. Lilly announced the successful completion of its acquisition of clinical-stage Versanis Bio and its lead asset bimagrumab, an anti-obesity medicine. Under the terms of the deal – first announced in July – Versanis shareholders could receive up to $1.925 billion in cash, inclusive of the upfront payment and subs

98
article thumbnail

8 drugs to avoid with diverticulitis

The Checkup by Singlecare

Diseases affecting the colon and GI tract can be excruciating and uncomfortable. Diverticulitis is a condition that can disrupt someone’s life with mild to severe symptoms. When in pain, people want relief quickly—which is why they may seek help from a medical professional. Healthcare providers can prescribe several treatments for diverticulitis, including prescription and over-the-counter medications.

article thumbnail

ATRAG formulations for lung disease

European Pharmaceutical Review

Swedish pharmaceutical company Vicore Pharma is developing treatments for diseases where the angiotensin II type 2 receptor (AT2R) has a central role in stopping and reversing disease pathology and where there is a large unmet medical need. The company’s lead candidate, C21, is an angiotensin II type 2 receptor agonist (ATRAG). It represents a new class of drugs capable of reducing pulmonary inflammation, proliferation, fibrosis, and vasculopathy.

article thumbnail

HebeCell and Logomix partner to develop PSC-NK cells

Pharmaceutical Technology

HebeCell has forged a strategic collaboration with Logomix for researching and developing gene-edited natural killer cells (NK cells).

98
article thumbnail

Natrol, Ashley Tisdale kick off Back on Track giveaway

Drug Store News

Fifty individuals have the chance to win a Back on Track Pack along with a $50 Target gift card.

98